Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Does radiation cause molecular signatures?

Conference ·
OSTI ID:526028
 [1]
  1. National Cancer Institute, Bethesda, MD (United States)
Several classes of genes are mutated during the progression to cancer. The oncogenes include ras, myc and c-erbB-2; suppressor genes include p53, Rb, p16, and APC; and cancer susceptibility genes include hMSH2. Germline mutations in many of these genes produce cancer syndromes such as retinoblastoma, Li-Fraumeni Sydrome, familial adenomatous polyposis, or HNPCC (hereditary non-polyposis colon cancer). Sporadic tumors frequently contain somatic mutations in the same genes. Analysis of the mutational spectrum of sporadic and inherited tumors can provide clues to etiology and insight into molecular pathogenesis. The character and distribution of mutations comprise a mutational spectrum. Mutations of the p53 tumor suppressor gene occur commonly in human cancer, and nearly 5000 have been reported to date. The p53 mutational spectrum is dominated by missense point mutations (84%) and complemented by insertions/deletions (10%) and non-sense mutations (7%). Most mutations occur within evolutionarily conserved residues within the DNA-binding domain, and the pattern of mutational hotspots provided the first clue to p53 function: it is a transcription factor that binds to a DNA consensus sequence. Elucidation of the crystal structure of the central DNA-binding domain has uncovered the significance of the mutational hotspots. These insights suggest strategies for rational drug design, for example, constructing `restoring` compounds that complete the wild type hydrogen bonds missing in the mutant p53 protein. Mutational spectrum analysis is a new tool for probing cancer etiology and pathogensis. Using current technology, the p53 tumor suppressor gene is the most informative target sequence, but the next generation of rapid sequencing technologies will expand the range of testable cancer genes and fill new mutational databases.
Research Organization:
National Council on Radiation Protection and Measurements, Bethesda, MD (United States)
OSTI ID:
526028
Report Number(s):
CONF-960405--
Country of Publication:
United States
Language:
English

Similar Records

Seven new mutations in hMSH2, an HNPCC Gene, identified by denaturing gradient-gel electrophoresis
Journal Article · Mon May 01 00:00:00 EDT 1995 · American Journal of Human Genetics · OSTI ID:75446

Mutator gene and hereditary non-polyposis colorectal cancer
Patent · Mon Feb 04 23:00:00 EST 2008 · OSTI ID:983105

Human MSH2 protein
Patent · Tue Dec 31 23:00:00 EST 1996 · OSTI ID:870772